tiprankstipranks
Advertisement
Advertisement

DBVT Stock Latest News

DBV Technologies price target lowered to EUR 1.01 from EUR 1.37 at Goldman Sachs
The FlyDBV Technologies price target lowered to EUR 1.01 from EUR 1.37 at Goldman Sachs
6d ago
DBVT
DBV Technologies price target raised to $47 from $45 at Citizens
PremiumThe Fly
DBV Technologies price target raised to $47 from $45 at Citizens
19d ago
DBVT
DBV Technologies S.A. – American Depositary Shares (DBVT) Q4 Earnings Cheat Sheet
PremiumPre-Earnings
DBV Technologies S.A. – American Depositary Shares (DBVT) Q4 Earnings Cheat Sheet
1M ago
DBVT
DBV Technologies Highlights Positive Phase 3 Peanut Patch Data
PremiumCompany Announcements
DBV Technologies Highlights Positive Phase 3 Peanut Patch Data
1M ago
8K
DBVT
DBV Technologies announces Phase 3 Vitesse trial met primary endpoint
PremiumThe Fly
DBV Technologies announces Phase 3 Vitesse trial met primary endpoint
2M ago
DBVT
Midday Fly By: Warner Bros. urges investors to reject Paramount bid
PremiumThe FlyMidday Fly By: Warner Bros. urges investors to reject Paramount bid
4M ago
PG
ABM
Morning News Wrap-Up: Wednesday’s Biggest Stock Market Stories!
Premium
Market News
Morning News Wrap-Up: Wednesday’s Biggest Stock Market Stories!
4M ago
AAL
AMD
DBV Technologies price target raised to $40 from $35 at H.C. Wainwright
Premium
The Fly
DBV Technologies price target raised to $40 from $35 at H.C. Wainwright
4M ago
DBVT
DBV Technologies Stock (DBVT) Soars as Clinical Trial Results Trigger Analyst Price Target Increases
PremiumMarket News
DBV Technologies Stock (DBVT) Soars as Clinical Trial Results Trigger Analyst Price Target Increases
4M ago
DBVT
DBV Technologies price target raised to $48 from $42 at Cantor Fitzgerald
PremiumThe Fly
DBV Technologies price target raised to $48 from $42 at Cantor Fitzgerald
4M ago
DBVT
Optimistic Buy Recommendation for DBV Technologies Driven by Viaskin Peanut’s Strong Clinical Results and Market Potential
PremiumRatings
Optimistic Buy Recommendation for DBV Technologies Driven by Viaskin Peanut’s Strong Clinical Results and Market Potential
4M ago
DBVT
DBV Technologies price target raised to $51 from $35 at Guggenheim
PremiumThe Fly
DBV Technologies price target raised to $51 from $35 at Guggenheim
4M ago
DBVT
DBV Technologies price target raised to $45 from $21 at Citizens
PremiumThe FlyDBV Technologies price target raised to $45 from $21 at Citizens
4M ago
DBVT
DBV Technologies trading resumes, shares up 65% to $29.60
Premium
The Fly
DBV Technologies trading resumes, shares up 65% to $29.60
4M ago
DBVT
DBV Technologies jumps 79% after peanut allergy study hits endpoint
Premium
The Fly
DBV Technologies jumps 79% after peanut allergy study hits endpoint
4M ago
DBVT
DBV Technologies Reports Positive Phase 3 Trial Results
PremiumCompany Announcements
DBV Technologies Reports Positive Phase 3 Trial Results
4M ago
8K
DBVT
DBV Technologies trading resumes
PremiumThe Fly
DBV Technologies trading resumes
4M ago
DBVT
DBV Technologies reports VITESSE trial meets primary endpoint
PremiumThe Fly
DBV Technologies reports VITESSE trial meets primary endpoint
4M ago
DBVT
DBV Technologies trading halted, news pending
PremiumThe Fly
DBV Technologies trading halted, news pending
4M ago
DBVT
DBV Technologies initiated with an Overweight at Cantor Fitzgerald
PremiumThe FlyDBV Technologies initiated with an Overweight at Cantor Fitzgerald
4M ago
DBVT
DBV Technologies price target raised to $35 from $20 at H.C. Wainwright
Premium
The Fly
DBV Technologies price target raised to $35 from $20 at H.C. Wainwright
4M ago
DBVT
DBV Technologies initiated with an Overweight at Cantor Fitzgerald
Premium
The Fly
DBV Technologies initiated with an Overweight at Cantor Fitzgerald
4M ago
DBVT

Trending

Name
Price
Price Change
SPX
S&P 500
―
DJIA
Dow Jones
―
NDX
Nasdaq 100
―
More Trending Stocks >